SERA PROGNOSTICS, INC. (SERA)
About SERA PROGNOSTICS, INC.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $81.0K
- Net income
- -$31.9M
- Total assets
- $101.9M
- Market cap
- $89.7M
- Gross margin
- -102.5%
- Operating margin
- -45066.7%
- Net margin
- -39417.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $81.0K
- Cost of revenue
- $164.0K
- Gross profit
- -$83.0K
- Operating expenses
- $36.6M
- Operating income
- -$36.5M
- Income tax
- $0
- Net income
- -$31.9M
- EPS (basic)
- $-0.67
- EPS (diluted)
- $-0.67
Balance sheet
- Total assets
- $101.9M
- Current assets
- $40.8M
- Total liabilities
- $26.5M
- Current liabilities
- $24.2M
- Shareholders’ equity
- $75.4M
Cash flow
- Operating cash flow
- -$25.6M
- Investing cash flow
- -$28.5M
- Financing cash flow
- $54.0M
- Net cash flow
- -$99.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $89.7M
- EPS (diluted)
- $-0.67
- Shares outstanding
- 43.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 15, 2021
Sera Prognostics, Inc. (SERA) Stock Price
- Reported a net loss of $31.9M in FY2025.
- Revenue declined 1% from FY2021 to FY2025.
- Gross margin of -102.5%, net margin -39417.3%.
- Trading 50% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review SERA PROGNOSTICS, INC..
Write a review
News about SERA PROGNOSTICS, INC.
News & sentiment via Polygon.io
Sera Prognostics, Inc.: frequently asked questions
Is Sera Prognostics, Inc. an American company?
Sera Prognostics, Inc. is a US-based company headquartered in Salt Lake City, Utah, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Sera Prognostics, Inc. headquartered?
Sera Prognostics, Inc. is headquartered in Salt Lake City, Utah, United States.
Is Sera Prognostics, Inc. publicly traded?
Yes — Sera Prognostics, Inc. is a publicly traded company. Its stock trades under the ticker symbol SERA on the NASDAQ.
What does Sera Prognostics, Inc. do?
Sera Prognostics, Inc. is an American Medical Devices company in the Health & Beauty sector.
